Skip to main content
Top

Drugs

Issue 2/2026

Content (11 Articles)

Lipid-Lowering Therapies in Patients with Chronic Kidney Disease: A Perspective on High-Density Lipoprotein Cholesterol

  • Review Article

Mohammad Abdullah Al Zubair Naim, Keiichi Sumida, Elani Streja, Fridtjof Thomas, Robert Lowell Davis, Kamyar Kalantar-Zadeh, Csaba P. Kovesdy

Treatment Sequencing in Advanced Urothelial Cancer

Irbaz B. Riaz, Muhammad Abdullah Humayun, Ali Raza Khaki, Syed A. Hussain

PCSK9 and ANGPTL3 Inhibitors in Homozygous Familial Hypercholesterolemia: A Meta-analysis of Randomized Clinical Trials

Ibadete Bytyçi, Michael Y. Henein, Sefer Bytyqi, Mentor Shatri, Drilon Gashi, Endrit Dragusha, Rozafa Koliqi, Shpend Elezi, Adrian V. Hernandez, Maciej Banach

Donidalorsen: First Approval

Yahiya Y. Syed

Taletrectinib: First Approval

  • NSCLC
  • AdisInsight Report

Sheridan M. Hoy

Paltusotine: First Approval

Arnold Lee

Brensocatib: First Approval

Susan J. Keam